Single Oral Toxicity of (R)-JG-381 in Sprague-Dawley Rats

SD랫드에서 (R)-JG-381의 단희경구독성시험

  • 이상호 (한국화학연구원 안전성연구센터) ;
  • 오우용 (한국화학연구원 안전성연구센터) ;
  • 김종춘 (한국화학연구원 안전성연구센터) ;
  • 주상섭 (서울대학교 약학대학) ;
  • 박형근 (서울대학교 약학대학) ;
  • 함광수 ((주)태평양제약 중앙연구소) ;
  • 조장섭 ((주)태평양제약 중앙연구소) ;
  • 이선미 (성균관대학교 약학대학)
  • Published : 2002.03.01


A single administration toxicity of (R)-JG-381 was studied in Sprague-Dawley rats of both sexes. In this study, rats were administered orally with dose of 50, 100, 200, 400 and 800 mg/kg of(R)-JG-381. We daily examined number of deaths, clinical signs, body weights and gross findings fur 14 days after (R)-JG-381 administration. When we administered different doses of 100, 200, 400 and 800 mg/kg, we found 5, 3, 5 and 5 male rats and 1, 4, 4 and 5 female rats dead within 1 day after administration, respectively. Some clinical signs(decrease of locomotor activity, decreased respiration rate, lacrimation, prone position) were observed during the experimental period. Our findings suggest that oral $LD_{50}s$(95% confidence limit) for male and female rats are 93.8mg/kg (28.8~161.6mg/kg) and 166.3mg/kg (89. I~284.8mg/kg), respectively.



  1. Agius, L., Mercdith, E. J. and Sherratt, H. S. (1991). Stereo-specificity of the inhibition by etomoxir of fatty acid and cholesterol synthesis in isolated rat hepatocytes. Biochem. Pharmacol. 9, 1717-1720
  2. Collier, G. R., Traianedes, K., Macaulay, S. L. and O'Dea, K-(1993). Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats. Horm. Metab. Res. 25, 9-12
  3. Ho, W., Tutwiler, G. F., Cottrell, S. C., Morgans, D. J., Tarhan, 0. and Mohrbacher, R. J. (1986). AIkylglycidic acids: potential new hypoglycemic agents. J. Med. Chem. 29, 2184-2190
  4. Martin, C., Odeon, M., Cohen, R. and Beylot, M. (1991). Mecha-nisms of the glucose lowering effect of a camiline palmitoyl transferase inhibitor in normal and diabetic rats. Metabolism. 40, 420-427
  5. Oh, W. Y., Lee, S. H., Kim, H. J., Jew, S. S., Park, H. G., Ham, K. S., Cho, J. S. and Lee, S. M. (2001). Single oral toxicity of JG-381 in rats. J Appl. Pharmacol. 9, 231-235
  6. Ratheiser, K.., Schneeweiss, B., Waldhausl, W., Fasching, P., Korn, A., Nowotny, P., Rohac, M. and Wolf, H. P. (1991). Inhibition by ctomoxir of camitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus. Metabolism. 40, 1185-1190
  7. Turcani, M. and RupP, H. (1999). Modification of left Ventri-cular hypertrophy by chronic etomixir treatment. Br. J. Pharmacol. 126, 501-507
  8. Wolf, H. P. (1992). Possible new therapeutic approach in diabetes mellitus by inhibition of carnitine Paimitoyltrans-ferase 1 (CPTl). Horm. Metab. Res. SuppI. 26, 62-67
  9. 식품의악품안전청(1999). 의약품등의 독성시힘기준, 식품의약품안전청고시 제1999-61호
  10. 식품의악품안전청(2000). 비임상시험 관리기준, 식품의약품안전청고시 제2000-63호